ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 40698358

Liquid Biopsy: Current advancements in clinical practice for bladder cancer.

Crocetto F and 17 others. J Liq Biopsy, 2025. Cited by 28 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Liquid Biopsy: Current advancements in clinical practice for bladder cancer. Papers, record 40698358. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40698358

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Liquid Biopsy: Current advancements in clinical practice for bladder cancer.
PubMed
Journal
J Liq Biopsy
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
7.26, provisional
iCite
Revised in PubMed
2025-07-25
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Crocetto FFelice
2Amicuzi UUgo
3Musone MMichele
4Magliocchetti MMarco
5Di Lieto DDario
6Tammaro SSimone
7Pastore ALAntonio Luigi
8Fuschi AAndrea
9Falabella RRoberto
10Ferro MMatteo

1 to 10 of 18Source PubMed

See all 18 authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References84

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122,099,989The FGFR3 mutation is related to favorable pT1 bladder cancer.J Urol2012https://conductscience.org/library/papers/22099989PubMed
217,360,461CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17360461PubMed
314,981,102p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.J Clin Oncol2004https://conductscience.org/library/papers/14981102PubMed
427,370,177Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.Eur Urol2017https://conductscience.org/library/papers/27370177PubMed
530,637,094Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.J Extracell Vesicles2018https://conductscience.org/library/papers/30637094PubMed
629,430,504Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer.Bladder Cancer2018https://conductscience.org/library/papers/29430504PubMed
726,119,560Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin.Eur Urol2016https://conductscience.org/library/papers/26119560PubMed
835,805,043Liquid Biopsy in Prostate Cancer Management-Current Challenges and Future Perspectives.Cancers (Basel)2022https://conductscience.org/library/papers/35805043PubMed
929,848,605Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.Cancer Discov2018https://conductscience.org/library/papers/29848605PubMed
1035,971,798New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index.Prostate2022https://conductscience.org/library/papers/35971798PubMed

1 to 10 of 84

See all 84 references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
42,979,574Preliminary development and internal evaluation of a plasma SOX1 methylation-based model bladder cancer detection.Open Life Sci2026https://conductscience.org/library/papers/42979574PubMed
42,957,299
Sequential intravesical mitomycin-C and gemcitabine therapy for BCG-unresponsive high-risk non-muscle-invasive bladder cancer: protocol for a prospective, open-label, single-arm, multicentre phase II (IMGeS) study.
BMJ Open2026https://conductscience.org/library/papers/42957299PubMed
42,500,328Epigenomics-Guided Multi-Omics Integration Uncovers a Lipid-Metabolic Signature with Translational Utility in Bladder Cancer.Comput Struct Biotechnol J2026https://conductscience.org/library/papers/42500328PubMed
42,481,967Non-invasive diagnostic evaluation of urinary exosomal let-7c cluster expression in bladder cancer using machine learning approaches.BMC Cancer2026https://conductscience.org/library/papers/42481967PubMed
42,443,785Unlocking the prognostic power of pathomics in bladder cancer: a machine learning odyssey across multiple centers.BMC Med Imaging2026https://conductscience.org/library/papers/42443785PubMed
42,401,786Multi-omics profiling identifies CDK1 as a key mediator of mitosis through the PTN pathway in bladder cancer.Future Sci OA2026https://conductscience.org/library/papers/42401786PubMed
42,311,269Liquid biopsy-guided kidney-sparing management in upper tract urothelial carcinoma: from preoperative risk stratification to perioperative surveillance.Front Oncol2026https://conductscience.org/library/papers/42311269PubMed
42,251,369Multi-dimensional profiling of lactylation-related signatures for prognostic and therapeutic insights in bladder cancer.Cancer Cell Int2026https://conductscience.org/library/papers/42251369PubMed
42,185,722Exploring XDH expression as a prognostic marker for urothelial carcinoma.Discov Oncol2026https://conductscience.org/library/papers/42185722PubMed
42,010,034Liquid biopsy in the clinical management of tumor of urinary system: current status and future developments.Cell Oncol (Dordr)2026https://conductscience.org/library/papers/42010034PubMed

1 to 10 of 23

See all 23 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EGFR1,956PubTator's text mininghttps://conductscience.org/library/genes/1956

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40698358

GET https://conductscience.org/api/papers/v1/40698358/references?page=2

API referenceFor AI assistants